iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

IBIO iBio Inc.

盘后交易 09-21 18:49:02 EDT

1.26

-0.02

-1.56%

盘后1.28

+0.02+1.53%

18:22 EDT

最高1.31	最低1.26	成交量38.56万
今开1.29	昨收1.28	日振幅3.52%
总市值8,103万	流通市值6,566万	总股本6,431万
成交额49.41万	换手率0.74%	流通股本5,211万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"IBIO","market":"US","secType":"STK","nameCN":"iBio Inc.","latestPrice":1.26,"timestamp":1790020800000,"preClose":1.28,"halted":0,"volume":385592,"hourTrading":{"tag":"盘后","latestPrice":1.2793,"preClose":1.26,"latestTime":"18:22 EDT","volume":3638,"amount":4617.516948,"timestamp":1790029378374,"change":0.0193,"changeRate":0.015317,"amplitude":0.023254},"delay":0,"changeRate":-0.015625000000000014,"floatShares":52111300,"shares":64307256,"eps":-0.317547,"marketStatus":"盘后交易","change":-0.02,"latestTime":"09-21 18:49:02 EDT","open":1.29,"high":1.305,"low":1.26,"amount":494059.8393432,"amplitude":0.035156,"askPrice":1.29,"askSize":50,"bidPrice":1.25,"bidSize":120,"shortable":3,"etf":0,"ttmEps":-0.317547,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1790035200000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1294117200000,"exchange":"NASDAQ","adjPreClose":1.28,"preHourTrading":{"tag":"盘前","latestPrice":1.29,"preClose":1.28,"latestTime":"09:29 EDT","volume":267,"amount":345.8873928,"timestamp":1789997372086,"change":0.01,"changeRate":0.007813,"amplitude":0.015625},"postHourTrading":{"tag":"盘后","latestPrice":1.2793,"preClose":1.26,"latestTime":"18:22 EDT","volume":3638,"amount":4617.516948,"timestamp":1790029378374,"change":0.0193,"changeRate":0.015317,"amplitude":0.023254},"volumeRatio":0.52907,"impliedVol":5.1303,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/IBIO","defaultTab":"news","newsList":[{"id":"1175700411","title":"iBio强化临床领导层，任命内分泌专家Molly Carr为首席医疗官","url":"https://stock-news.laohu8.com/highlight/detail?id=1175700411","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1175700411?lang=zh_cn&edition=full","pubTime":"2026-08-04 19:01","pubTimestamp":1785841280,"startTime":"0","endTime":"0","summary":"iBio公司（iBio Inc.）如今正大力强化其临床领导团队。公司近日宣布，任命内分泌学专家Molly Carr博士担任首席医疗官一职。这一战略举措，旨在进一步提升其临床开发的专业深度与执行能力。\nMolly Carr的加入，被视作iBio发展进程中的关键一步。她不仅拥有深厚的医学背景，更在内分泌领域积累了丰富的临床经验。作为新任首席医疗官，她将负责监督公司的临床开发项目，并主导相关战略规划。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132883856","title":"iBio宣布单剂量IBIO-610在肥胖非人灵长类动物研究中实现近完全活性激活素E抑制，效果持续八周","url":"https://stock-news.laohu8.com/highlight/detail?id=1132883856","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1132883856?lang=zh_cn&edition=full","pubTime":"2026-07-01 19:06","pubTimestamp":1782903981,"startTime":"0","endTime":"0","summary":"iBio Inc. 公布了一项研究结果，显示在肥胖非人灵长类动物模型中，单次施用候选药物IBIO-610可在长达八周的时间内，实现近乎完全的活性激活素E抑制。该数据揭示了该疗法在靶向这一特定通路方面具有持久的药理活性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106176872","title":"iBio Inc. 迈入临床阶段：首例肥胖成人患者接受 Ibio-600 一期临床试验给药","url":"https://stock-news.laohu8.com/highlight/detail?id=1106176872","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1106176872?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:02","pubTimestamp":1780398121,"startTime":"0","endTime":"0","summary":"iBio Inc. 迎来关键里程碑，其针对肥胖成人患者的 Ibio-600 一期临床试验已完成首例受试者给药，标志着公司正式迈入临床阶段公司行列。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4568","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517116539","title":"Ibio, Inc.盘中异动 早盘股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517116539","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517116539?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:39","pubTimestamp":1741271983,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时39分，Ibio, Inc.股票出现波动，股价急速跳水5.21%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。其相关个股中，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 涨幅较大，Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为1137.52%、233.04%、55.06%，振幅较大的相关个股有Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 ，振幅分别为31.46%、30.53%、23.12%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223944abeb7a0b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223944abeb7a0b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517410943","title":"Ibio, Inc.盘中异动 股价大涨6.66%报6.35美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517410943","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517410943?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:30","pubTimestamp":1741185059,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时30分，Ibio, Inc.股票出现波动，股价急速拉升6.66%。截至发稿，该股报6.35美元/股，成交量3.6554万股，换手率0.37%，振幅0.00%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059963adc07&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223059963adc07&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4139","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516347676","title":"Ibio, Inc.盘中异动 早盘股价大涨6.00%报6.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516347676","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516347676?lang=zh_cn&edition=full","pubTime":"2025-03-03 22:34","pubTimestamp":1741012470,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日22时34分，Ibio, Inc.股票出现异动，股价急速上涨6.00%。截至发稿，该股报6.18美元/股，成交量14.6236万股，换手率1.48%，振幅8.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303223430989a1038&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514731543","title":"Ibio, Inc.盘中异动 早盘大幅下挫5.15%报4.79美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514731543","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514731543?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:56","pubTimestamp":1740754616,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时56分，Ibio, Inc.股票出现波动，股价大幅跳水5.15%。截至发稿，该股报4.79美元/股，成交量27.218万股，换手率2.76%，振幅7.92%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.30%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228225656abe0f146&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514838859","title":"Ibio, Inc.盘中异动 股价大涨7.20%报4.17美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514838859","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514838859?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:33","pubTimestamp":1740580409,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时33分，Ibio, Inc.股票出现波动，股价急速拉升7.20%。截至发稿，该股报4.17美元/股，成交量14.0798万股，换手率1.43%，振幅5.66%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.09%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223329abdded67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223329abdded67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514900770","title":"Ibio, Inc.盘中异动 股价大涨5.23%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514900770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514900770?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:44","pubTimestamp":1740494666,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时44分，Ibio, Inc.股票出现异动，股价快速拉升5.23%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。其相关个股中，Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Abpro Holdings Inc C/Wts 12/11/2029 涨幅较大，Gt Biopharma, Inc.、Organovo Holdings, Inc.、Moleculin Biotech, Inc.较为活跃，换手率分别为855.06%、620.78%、532.76%，振幅较大的相关个股有Organovo Holdings, Inc.、Adial Pharmaceuticals, Inc、Gt Biopharma, Inc.，振幅分别为100.27%、46.65%、33.50%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224426962ff597&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224426962ff597&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513727532","title":"Ibio, Inc.盘中异动 早盘股价大涨5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513727532","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513727532?lang=zh_cn&edition=full","pubTime":"2025-02-24 22:38","pubTimestamp":1740407901,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日22时38分，Ibio, Inc.股票出现波动，股价大幅上涨5.17%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Pepgen Inc.、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为52.60%、46.77%、24.53%，振幅较大的相关个股有Pepgen Inc.、Vaxart, Inc. - Common Stock、Gossamer Bio, Inc.，振幅分别为92.70%、21.42%、14.69%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224223822962e9a43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","IBIO","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512644271","title":"Ibio, Inc.盘中异动 早盘急速拉升6.41%报3.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512644271","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512644271?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:06","pubTimestamp":1739894765,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时06分，Ibio, Inc.股票出现波动，股价快速上涨6.41%。截至发稿，该股报3.65美元/股，成交量10.9246万股，换手率1.11%，振幅5.25%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.88%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000605988a0e41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219000605988a0e41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511521300","title":"Ibio, Inc.盘中异动 早盘股价大跌5.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511521300","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511521300?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:13","pubTimestamp":1739459599,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时13分，Ibio, Inc.股票出现异动，股价大幅跳水5.57%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.10%。其相关个股中，Edesa Biotech, Inc.、Enanta Pharmaceuticals, Inc.、Nutriband Inc C/Wts 涨幅较大，Edesa Biotech, Inc.、Tc Biopharm  Plc、Genprex, Inc.较为活跃，换手率分别为1752.95%、1117.32%、140.15%，振幅较大的相关个股有Immatics N V C/Wts 01/07/2025 、Edesa Biotech, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 ，振幅分别为92.30%、73.65%、32.86%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231319a244b4d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213231319a244b4d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510538740","title":"Ibio, Inc.盘中异动 早盘股价大跌6.14%报3.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510538740","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2510538740?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:32","pubTimestamp":1739284335,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时32分，Ibio, Inc.股票出现波动，股价大幅跳水6.14%。截至发稿，该股报3.21美元/股，成交量1.6733万股，换手率0.17%，振幅1.61%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为1.10%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223215a241fb55&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211223215a241fb55&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OCEA","IBIO","BK4568","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162731855","title":"iBio 第二季度每股收益 $(0.48) 未能达到预期 $(0.32)，销售额为 $200.00K","url":"https://stock-news.laohu8.com/highlight/detail?id=1162731855","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1162731855?lang=zh_cn&edition=full","pubTime":"2025-02-11 05:26","pubTimestamp":1739222778,"startTime":"0","endTime":"0","summary":"iBio  报告其季度每股亏损 $，未能达到分析师共识预期的 $，差距为 50%。这相比去年同期每股亏损 $ 增长了 80.17%。该公司本季度报告销售额为 $200.00千美元。以上内容来自Benzinga Earnings专栏，原文如下：iBio  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 50 percent. This is a 80.17 percent increase over losses of $ per share from the same period last year.  The company reported $200.00 thousand in sales this quarter.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"iBio 第二季度每股收益 $(0.48) 未能达到预期 $(0.32)，销售额为 $200.00K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509256848","title":"Ibio, Inc.盘中异动 急速上涨5.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509256848","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509256848?lang=zh_cn&edition=full","pubTime":"2025-02-06 04:37","pubTimestamp":1738787836,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日04时37分，Ibio, Inc.股票出现波动，股价快速上涨5.35%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为2.38%。其相关个股中，Immatics N V C/Wts 01/07/2025 、Invivyd, Inc.、Transcode Therapeutics, Inc.涨幅较大，Pasithea Therapeutics Corp.、Transcode Therapeutics, Inc.、Oragenics Inc.较为活跃，换手率分别为4694.80%、2439.13%、1782.57%，振幅较大的相关个股有Oragenics Inc.、Transcode Therapeutics, Inc.、Invivyd, Inc.，振幅分别为132.24%、99.51%、96.79%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043716987bb513&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206043716987bb513&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4568","IBIO"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509493643","title":"Ibio, Inc.盘中异动 下午盘急速上涨5.11%报3.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509493643","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2509493643?lang=zh_cn&edition=full","pubTime":"2025-02-05 03:17","pubTimestamp":1738696620,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日03时17分，Ibio, Inc.股票出现波动，股价快速拉升5.11%。截至发稿，该股报3.29美元/股，成交量18.7977万股，换手率2.00%，振幅5.43%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为1.51%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205031700abc25c3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205031700abc25c3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506512077","title":"Ibio, Inc.盘中异动 股价大跌5.37%报2.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506512077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506512077?lang=zh_cn&edition=full","pubTime":"2025-01-28 23:11","pubTimestamp":1738077084,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日23时11分，Ibio, Inc.股票出现异动，股价大幅下跌5.37%。截至发稿，该股报2.82美元/股，成交量9.1419万股，换手率0.97%，振幅7.44%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231124a23277b0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250128231124a23277b0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2506588869","title":"Ibio, Inc.盘中异动 急速下跌5.21%报2.91美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506588869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506588869?lang=zh_cn&edition=full","pubTime":"2025-01-28 01:21","pubTimestamp":1737998518,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日01时21分，Ibio, Inc.股票出现异动，股价急速下挫5.21%。截至发稿，该股报2.91美元/股，成交量16.5684万股，换手率1.76%，振幅6.19%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为0.97%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280121599874ca31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501280121599874ca31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505798869","title":"Ibio, Inc.盘中异动 股价大跌8.31%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505798869","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505798869?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:42","pubTimestamp":1737729759,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时42分，Ibio, Inc.股票出现异动，股价快速下挫8.31%。截至发稿，该股报2.76美元/股，成交量3.2841万股，换手率0.35%，振幅4.65%。Ibio, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242242409872043c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501242242409872043c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IBIO","BK4139","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505499277","title":"Ibio, Inc.盘中异动 急速拉升6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505499277","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505499277?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:27","pubTimestamp":1737473256,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时27分，Ibio, Inc.股票出现异动，股价快速上涨6.71%。Ibio, Inc.股票所在的生物技术行业中，整体涨幅为1.30%。其相关个股中，Channel Therapeutics Corporation、Dogwood Therapeutics, Inc.、Genelux Corporation涨幅较大，Dogwood Therapeutics, Inc.、Channel Therapeutics Corporation、Dermata Therapeutics, Inc.较为活跃，换手率分别为717.04%、248.12%、172.95%，振幅较大的相关个股有Channel Therapeutics Corporation、Klotho Neurosciences Inc C/Wts 21/06/2029 、Dogwood Therapeutics, Inc.，振幅分别为92.63%、41.33%、38.48%。Ibio, Inc.公司简介：iBio公司是一家临床前阶段生物技术公司，利用人工智能的力量开发精准抗体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232736abb3542e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121232736abb3542e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","IBIO","BK4568"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ibioinc.com","stockEarnings":[{"period":"1week","weight":0.0622},{"period":"1month","weight":-0.1409},{"period":"3month","weight":-0.2426},{"period":"6month","weight":-0.3876},{"period":"1year","weight":0.4713},{"period":"ytd","weight":-0.3368}],"compareEarnings":[{"period":"1week","weight":-0.0034},{"period":"1month","weight":-0.0096},{"period":"3month","weight":0.02},{"period":"6month","weight":0.1744},{"period":"1year","weight":0.1501},{"period":"ytd","weight":0.117}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"iBio, Inc.于2008年4月17日根据特拉华州法律注册成立，名称为iBioPharma, Inc.，2008年7月25日与新泽西州的Biotechnologies, Inc.合并，并于2009年8月10日更名为iBio, Inc.。iBio是一家临床前阶段的生物技术公司，利用人工智能（AI）的力量开发精准抗体。该公司的专有技术堆栈旨在通过采用AI引导的表位指导和单克隆抗体（mAb）优化来最大限度地降低下游开发风险。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.132537},{"month":2,"riseRate":0.625,"avgChangeRate":0.661576},{"month":3,"riseRate":0.4375,"avgChangeRate":0.11465},{"month":4,"riseRate":0.25,"avgChangeRate":-0.132363},{"month":5,"riseRate":0.375,"avgChangeRate":-0.046566},{"month":6,"riseRate":0.5,"avgChangeRate":0.982354},{"month":7,"riseRate":0.1875,"avgChangeRate":-0.055478},{"month":8,"riseRate":0.3125,"avgChangeRate":-0.053256},{"month":9,"riseRate":0.5,"avgChangeRate":-0.040389},{"month":10,"riseRate":0.266667,"avgChangeRate":-0.012402},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.143238},{"month":12,"riseRate":0.133333,"avgChangeRate":-0.108408}],"exchange":"NASDAQ","name":"iBio Inc.","nameEN":"iBio"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供iBio Inc.(IBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"iBio Inc.,IBIO,iBio Inc.股票,iBio Inc.股票老虎,iBio Inc.股票老虎国际,iBio Inc.行情,iBio Inc.股票行情,iBio Inc.股价,iBio Inc.股市,iBio Inc.股票价格,iBio Inc.股票交易,iBio Inc.股票购买,iBio Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"iBio Inc.(IBIO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供iBio Inc.(IBIO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}